Clinical commentary, research updates, recent articles and event coverage from the FMI editorial team.
The longevity field has moved from the margins of gerontology to the front pages of science journals and the portfolios of billion-dollar biotech firms. We critically examine the twelve hallmarks of ageing, the distinction between healthspan and lifespan, and which interventions the human evidence actually supports.
Read Article →